Internal Medicine, Cardiovascular Disease · Houston, TX
NPI
1003874371
Since 2006
Specialty
Internal Medicine, Cardiovascular Disease
Code 207RC0000X
Group practices
2
Medicare group memberships
Hospitals
5
Hospital affiliations
5115 Fannin St Ste 801
Houston, TX, 77004
Phone (713) 790-0841
Groups this clinician bills Medicare through
Medicare paid, 2024
$1.7M
10,751 services
Medicare patients, 2024
1,105
Average age 77
Drug cost, 2024
$1.4M
13,020 prescriptions
Company payments, 2025
$3,011
From 12 companies
Procedures and visits billed to Original Medicare, 2024
In 2024, the most common Medicare service billed by Earl L Mangin Jr. was code J2785 (injection, regadenoson, 0.1 mg), 2,560 times for 629 patients. In total Earl L Mangin Jr. billed 10,751 services in 91 codes, and Medicare paid $1.7M.
| Code |
|---|
Official US government data: the national provider registry and Medicare enrollment records, linked by NPI. Last update of this record: 2024-05-22.
| Setting |
|---|
| Services |
|---|
| Patients |
|---|
| Paid per service |
|---|
| Medicare paid |
|---|
| J2785 Injection, regadenoson, 0.1 mg | Office | 2,560 | 629 | $5.54 | $14K |
| 99214 Office E&M - Established | Office | 1,262 | 780 | $88.57 | $112K |
| 93000 Electrocardiogram | Office | 1,025 | 658 | $9.75 | $9,989 |
| 93306 Echocardiography (TTE/TEE) | Office | 841 | 817 | $126.09 | $106K |
| 93015 Electrocardiogram | Office | 643 | 632 | $52.25 | $34K |
| A9555 Rubidium rb-82, diagnostic, per study dose, up to 60 millicuries | Office | 611 | 597 | $621.68 | $380K |
| 78492 Myocardial Perfusion Scan | Office | 478 | 473 | $1,151.57 | $550K |
| 99232 Hospital E&M - Subsequent | Facility | 369 | 116 | $59.56 | $22K |
| 93294 External Electrocardiographic Monitoring | Office | 366 | 108 | $21.92 | $8,023 |
| 93880 Duplex Scan - Extracranial Arteries | Office | 318 | 315 | $136.35 | $43K |
| 93297 External Electrocardiographic Monitoring | Office | 287 | 34 | $19.00 | $5,453 |
| 93298 External Electrocardiographic Monitoring | Office | 236 | 37 | $19.57 | $4,618 |
| 93288 External Electrocardiographic Monitoring | Office | 147 | 91 | $39.38 | $5,790 |
| 93306 Echocardiography (TTE/TEE) | Facility | 145 | 118 | $51.53 | $7,473 |
| 78431 Myocardial Perfusion Scan | Office | 129 | 127 | $1,849.08 | $239K |
By year: 2022 $1.9M for 11,416 services; 2023 $1.8M for 11,049 services; 2024 $1.7M for 10,751 services.
Medicare prescription drug claims, 2024
In 2024, the drug Earl L Mangin Jr. prescribed most often to Medicare patients was Metoprolol Succinate, with 885 prescriptions and refills. In total Earl L Mangin Jr. wrote 13,020 Medicare prescriptions that cost $1.4M.
| Drug | Claims | 30-day fills | Patients | Cost |
|---|---|---|---|---|
| Metoprolol Succinate Generic | 885 | 2,046 | 247 | $13K |
| Carvedilol Generic | 831 | 1,887 | 204 | $6,250 |
| Lisinopril Generic | 767 | 1,891 | 200 | $6,242 |
| Eliquis Apixaban | 762 | 1,231 | 146 | $697K |
| Atorvastatin Calcium Generic | 625 | 1,741 | 190 | $5,897 |
| Amlodipine Besylate Generic | 610 | 1,402 | 162 | $4,138 |
| Clopidogrel Clopidogrel Bisulfate | 588 | 1,535 | 156 | $6,701 |
| Valsartan Generic | 537 | 1,161 | 131 | $17K |
| Digoxin Generic | 472 | 1,046 | 120 | $10K |
| Furosemide Generic | 390 | 885 | 119 | $2,202 |
| Potassium Chloride Generic | 364 | 710 | 103 | $5,911 |
| Metoprolol Tartrate Generic | 353 | 821 | 96 | $2,654 |
| Isosorbide Mononitrate Er Isosorbide Mononitrate | 347 | 857 | 98 | $5,793 |
| Rosuvastatin Calcium Generic | 296 | 716 | 85 | $3,001 |
| Triamterene-Hydrochlorothiazid Triamterene/Hydrochlorothiazid | 277 | 628 | 78 | $2,198 |
Brand drugs: 1,555 claims; generic drugs: 11,465 claims.
Money and other things of value reported by the companies
In 2025, drug and medical device companies paid Earl L Mangin Jr. $3,011 ($3,011 in general payments such as food, travel and fees) from 12 companies. The largest payer was Medtronic, Inc. with $1,149.
| Company | Payments | Amount |
|---|---|---|
| Medtronic, Inc. MDT | 13 | $1,149 |
| Edwards Lifesciences Corporation EW | 5 | $487 |
| Elutia, Inc. ELUT | 4 | $373 |
| Boston Scientific Corporation BSX | 12 | $272 |
| Novartis Pharmaceuticals Corporation NVS | 8 | $219 |
| Abbott Laboratories ABT | 4 | $210 |
| Abiomed JNJ | 3 | $123 |
| Amgen Inc. AMGN | 6 | $113 |
| Novo Nordisk Inc NVO | 1 | $24.56 |
| Pfizer Inc. PFE | 1 | $18.76 |
Official US government data on Original Medicare services, Medicare prescription drug plans and the payments drug and device companies must report. Services with fewer than 11 patients and drugs with fewer than 11 claims are not published. Procedure codes are shown by number with their public category.